How to improve effectiveness and adherence to antihypertensive drug therapy: central role of dihydropyridinic calcium channel blockers in hypertension

G Tocci, G Desideri, E Roca, C Calcullo… - High Blood Pressure & …, 2018 - Springer
Essential hypertension is a complex clinical condition, characterized by multiple and
concomitant abnormal activation of different regulatory and contra-regulatory …

Calcium channel blockers and hypertension

G Tocci, A Battistoni, J Passerini… - Journal of …, 2015 - journals.sagepub.com
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the
burden of hypertension-related cardiovascular and renal diseases. In spite of these well …

Effective management of hypertension with dihydropyridine calcium channel blocker‐based combination therapy in patients at high cardiovascular risk

H Haller - International journal of clinical practice, 2008 - Wiley Online Library
The increasing prevalence of hypertension, owing to modern lifestyles and the increasing
elderly population, is contributing to the global burden of cardiovascular (CV) disease …

Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?

M Burnier, M Pruijm, G Wuerzner - Expert opinion on drug …, 2009 - Taylor & Francis
In all actual clinical guidelines, dihydropyridine calcium channel blockers (CCBs) belong to
the recommended first line antihypertensive drugs to treat essential hypertension. Several …

Dihydropyridine calcium channel antagonists in the management of hypertension

BJ Epstein, K Vogel, BF Palmer - Drugs, 2007 - Springer
Dihydropyridine calcium channel antagonists have been maligned in recent years because
of concerns regarding their cardiovascular and overall safety profile. Specifically, it was …

Effects of long-and intermediate-acting dihydropyridine calcium channel blockers in hypertension: a systematic review and meta-analysis of 18 prospective …

S Chaugai, LY Sherpa, AA Sepehry… - Journal of …, 2018 - journals.sagepub.com
Background: Dihydropyridine calcium channel blockers are a heterogeneous group of
antihypertensive drugs. Long-acting dihydropyridine agent amlodipine is widely used for …

Calcium channel blockers as initial therapeutic agents in hypertension: relationship to incident heart failure

DL Shields - Biological Research for Nursing, 2014 - journals.sagepub.com
Blood pressure (BP) control is central to health promotion and maintenance across the
health care continuum. Optimal control has been associated with improved microvascular …

[HTML][HTML] Calcium channel blockers for hypertension: Old, but still useful

EM Lee - Cardiovascular Prevention and Pharmacotherapy, 2023 - e-jcpp.org
Calcium channel blockers (CCBs) constitute a heterogeneous class of drugs that can be
divided into dihydropyridines (DHPs) and non-DHPs. DHP-CCBs are subcategorized into …

Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials

JA Staessen, Y Li, L Thijs, JG Wang - Hypertension Research, 2005 - nature.com
In a meta-analysis published in June 2003, we reported that new and old classes of
antihypertensive drugs had similar long-term efficacy and safety. Furthermore, we observed …

[PDF][PDF] The role of dihydropyridine calcium channel blockers in the treatment of hypertension and cardiovascular disease–An update

FH Messerli, G Noll, LH Lindholm, H Haller… - Eur Cardiovasc …, 2006 - researchgate.net
Outcome with Nifedipine GITS (ACTION) study in which nifedipine GITS was compared with
placebo, significant reductions of 28% and 27% were seen the incidence of any stroke or …